(28) However, GLP-1 agonists did have a lower all-cause mortality rate compared to other agents, but it came at the highest healthcare cost
In recent GLP-1RA trials focusing on patients with obesity, favourable effect on worsening heart failure in HFpEF patients was indicated to be modulated by baseline BMI [32], although the underlying mechanisms that explain the cardiovascular and renal benefits may not necessarily be due to weight loss alone
Once replete her body obviously csn store and use the B12 if available
Emsculpt has been proven effective through seven independent, multi-center studies
But an association seen in groups of patients is a long way from a prediction about any one person, and the authors note that the causes of a high B12 are multiple and its consequences not clearly established
Thats simply what BPC stands for